Journal of Vascular Surgery
Volume 49, Issue 5 , Pages 1140-1146 , May 2009

Systemic inflammation, coagulopathy, and acute renal insufficiency following endovascular thoracoabdominal aortic aneurysm repair

  • Catherine K. Chang, MD

      Affiliations

    • Department of Surgery, Division of Vascular Surgery, University of California at San Francisco, San Francisco, Calif
    • ,
  • Timothy A.M. Chuter, MD

      Affiliations

    • Department of Surgery, Division of Vascular Surgery, University of California at San Francisco, San Francisco, Calif
    • ,
  • Claus U. Niemann, MD

      Affiliations

    • Department of Anesthesia and Perioperative Care, University of California at San Francisco, San Francisco, Calif
    • University of California at San Francisco, San Francisco, Calif
    • ,
  • Michael G. Shlipak, MD

      Affiliations

    • General Internal Medicine Section, San Francisco Veterans Affairs Medical Center, San Francisco, Calif
    • ,
  • Mitchell J. Cohen, MD

      Affiliations

    • Department of Surgery, Division of Transplantation, University of California at San Francisco, San Francisco, Calif
    • ,
  • Linda M. Reilly, MD

      Affiliations

    • Department of Surgery, Division of Vascular Surgery, University of California at San Francisco, San Francisco, Calif
    • ,
  • Jade S. Hiramoto, MD

      Affiliations

    • Department of Surgery, Division of Vascular Surgery, University of California at San Francisco, San Francisco, Calif
    • Corresponding Author InformationReprint requests: Jade S. Hiramoto, MD, University of California, San Francisco, Division of Vascular Surgery, 400 Parnassus Ave, A-581, San Francisco, CA 94143-0222

Received 13 September 2008 ,Accepted 29 November 2008.

References 

  1. Crawford ES, DeNatale RW. Thoracoabdominal aortic aneurysm: observations regarding the natural course of the disease. J Vasc Surg. 1986;3:578–582
  2. Rigberg DA, McGory ML, Zingmond DS, Maggard MA, Agustin M, Lawrence PF, et al. Thirty-day mortality statistics underestimate the risk of repair of thoracoabdominal aortic aneurysms: a statewide experience. J Vasc Surg. 2006;43:217–222discussion 223.
  3. Chuter TA, Reilly LM. Endovascular treatment of thoracoabdominal aortic aneurysms. J Cardiovasc Surg (Torino). 2006;47:619–628
  4. Roselli EE, Greenberg RK, Pfaff K, Francis C, Svensson LG, Lytle BW. Endovascular treatment of thoracoabdominal aortic aneurysms. J Thorac Cardiovasc Surg. 2007;133:1474–1482
  5. Chuter TA, Rapp JH, Hiramoto JS, Schneider DB, Howell B, Reilly LM. Endovascular treatment of thoracoabdominal aortic aneurysms. J Vasc Surg. 2008;47:6–16
  6. Peterson BG, Matsumura JS, Brewster DC, Makaroun MS. Five-year report of a multicenter controlled clinical trial of open versus endovascular treatment of abdominal aortic aneurysms. J Vasc Surg. 2007;45:885–890
  7. Hiramoto JS, Reilly LM, Schneider DB, Sivamurthy N, Rapp JH, Chuter TA. Long-term outcome and reintervention after endovascular abdominal aortic aneurysm repair using the Zenith stent graft. J Vasc Surg. 2007;45:461–465discussion 465-6.
  8. Blum U, Voshage G, Lammer J, Beyersdorf F, Töllner D, Kretschmer G, et al. Endoluminal stent-grafts for infrarenal abdominal aortic aneurysms. N Engl J Med. 1997;336:13–20
  9. Velazquez OC, Carpenter JP, Baum RA, Barker CF, Golden M, Criado F, et al. Perigraft air, fever, and leukocytosis after endovascular repair of abdominal aortic aneurysms. Am J Surg. 1999;178:185–189
  10. Galle C, De Maertelaer V, Motte S, Zhou L, Stordeur P, Delville JP, et al. Early inflammatory response after elective abdominal aortic aneurysm repair: a comparison between endovascular procedure and conventional surgery. J Vasc Surg. 2000;32:234–246
  11. Swartbol P, Norgren L, Albrechtsson U, Cwikiel W, Jahr J, Jonung T, et al. Biological responses differ considerably between endovascular and conventional aortic aneurysm surgery. Eur J Vasc Endovasc Surg. 1996;12:18–25
  12. Norgren L, Albrechtsson U, Swartbol P. Side-effect of endovascular grafting to treat aortic aneurysm. Br J Surg. 1996;83:520–521
  13. Gerasimidis T, Sfyroeras G, Trellopoulos G, Skoura L, Papazoglou K, Konstantinidis K, et al. Impact of endograft material on the inflammatory response after elective endovascular abdominal aortic aneurysm repair. Angiology. 2005;56:743–753
  14. Cross KS, Bouchier-Hayes D, Leahy AL. Consumptive coagulopathy following endovascular stent repair of abdominal aortic aneurysm. Eur J Vasc Endovasc Surg. 2000;19:94–95
  15. Liu KD, Glidden DV, Eisner MD, Parsons PE, Ware LB, Wheeler A, et al. Predictive and pathogenetic value of plasma biomarkers for acute kidney injury in patients with acute lung injury. Crit Care Med. 2007;35:2755–2761
  16. Levey AS, Bosch JP, Lewis JB, Greene T, Rogers N, Roth D. A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation (Modification of Diet in Renal Disease Study Group). Ann Intern Med. 1999;130:461–470
  17. Morikage N, Esato K, Zenpo N, Fujioka K, Takenaka H. Is endovascular treatment of abdominal aortic aneurysms less invasive regarding the biological responses?. Surg Today. 2000;30:142–146
  18. Swartbol P, Truedsson L, Norgren L. Adverse reactions during endovascular treatment of aortic aneurysms may be triggered by interleukin 6 release from the thrombotic content. J Vasc Surg. 1998;28:664–668
  19. Nguyen MT, Devarajan P. Biomarkers for the early detection of acute kidney injury. Pediatr Nephrol. 2008;23:2151–2157
  20. Trof RJ, Di Maggio F, Leemreis J, Groeneveld AB. Biomarkers of acute renal injury and renal failure. Shock. 2006;26:245–253
  21. Coll E, Botey A, Alvarez L, Poch E, Quintó L, Saurina A, et al. Serum cystatin C as a new marker for noninvasive estimation of glomerular filtration rate and as a marker for early renal impairment. Am J Kidney Dis. 2000;36:29–34
  22. Chantrel F, Agin A, Offner M, Koehl C, Moulin B, Hannedouche T. Comparison of cystatin C versus creatinine for detection of mild renal failure. Clin Nephrol. 2000;54:374–381
  23. Harmoinen AP, Kouri TT, Wirta OR, Lehtimäki TJ, Rantalaiho V, Turjanmaa VM, et al. Evaluation of plasma cystatin C as a marker for glomerular filtration rate in patients with type 2 diabetes. Clin Nephrol. 1999;52:363–370
  24. Price CP, Finney H. Developments in the assessment of glomerular filtration rate. Clin Chim Acta. 2000;297:55–66
  25. Mishra J, Dent C, Tarabishi R, Mitsnefes MM, Ma Q, Kelly C, et al. Neutrophil gelatinase-associated lipocalin (NGAL) as a biomarker for acute renal injury after cardiac surgery. Lancet. 2005;365:1231–1238
  26. Akowuah E, Wilde P, Angelini G, Bryan AJ. Systemic inflammatory response after endoluminal stenting of the descending thoracic aorta. Interact Cardiovasc Thorac Surg. 2007;6:741–743
  27. Eggebrecht H, Mehta RH, Metozounve H, Huptas S, Herold U, Jakob HG, et al. Clinical implications of systemic inflammatory response syndrome following thoracic aortic stent-graft placement. J Endovasc Ther. 2008;15:135–143
  28. Gabriel EA, Locali RF, Romano CC, Duarte AJ, Palma JH, Buffolo E. Analysis of the inflammatory response in endovascular treatment of aortic aneurysms. Eur J Cardiothorac Surg. 2007;31:406–412

 This project was supported by National Institutes of Health (NIH)/National Center for Research Resources (NCRR)/OD University of California, San Francisco (UCSF)-Clinical and Translational Science Institute (CTSI) Grant Number KL2 RR024130 (Dr Hiramoto) and NIH K08 GM-085689 (Dr Cohen). Its contents are the responsibility of the authors and do not necessarily represent the official views of the NIH. This study was also supported in part by grants from the Hellman Award, San Francisco, CA (Dr Hiramoto); the Research Evaluation and Allocation Committee, San Francisco, CA (Dr Hiramoto); the Foundation of Anesthesia Research and Education, Rochester, MN (Dr Niemann); the International Anesthesia Research Society, Cleveland, OH (Dr Niemann); the Foundation for Accelerated Vascular Research, San Francisco, CA (Drs Chang and Chuter); and the Established Investigator Award from the American Heart Association (Dr Shlipak). The Clinicaltrials.gov number is: NCT00483249.

 Conflict of interest: Dr. Chuter has licensed patents to Cook Medical, Inc. and receives travel and research support from Cook Medical, Inc.

PII: S0741-5214(08)02111-3

doi: 10.1016/j.jvs.2008.11.102

Journal of Vascular Surgery
Volume 49, Issue 5 , Pages 1140-1146 , May 2009

Article Tools

* Image Usage & Resolution